| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tyra Biosciences, Inc. | Other* | Common Stock | 4,448,359 | $125,264,455 | $28.16 | 18 Oct 2024 | Indirect |
| Tango Therapeutics, Inc. | Other* | Common Stock | 3,610,642 | $11,337,416 | $3.14 | 06 Nov 2024 | Indirect |
| Tyra Biosciences, Inc. | Other* | Pre-Funded Warrant (right to purchase) | 2,705,280 | 18 Oct 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TNGX | Tango Therapeutics, Inc. | 06 Nov 2024 | 1 | -$9,671,200 | 4 | Other* | 07 Nov 2024, 21:30 |
| TNGX | Tango Therapeutics, Inc. | 25 Oct 2024 | 1 | -$4,348,710 | 4 | Other* | 28 Oct 2024, 06:59 |
| TNGX | Tango Therapeutics, Inc. | 21 Oct 2024 | 2 | -$6,101,250 | 4 | Other* | 23 Oct 2024, 21:31 |
| TYRA | Tyra Biosciences, Inc. | 18 Oct 2024 | 2 | $0 | 4 | Other* | 22 Oct 2024, 20:49 |
| TNGX | Tango Therapeutics, Inc. | 10 Oct 2024 | 0 | $0 | 3 | Other* | 22 Oct 2024, 20:48 |
| TYRA | Tyra Biosciences, Inc. | 10 Oct 2024 | 0 | $0 | 3 | Other* | 22 Oct 2024, 20:47 |